Elevated brain levels of MMP3 have been associated with the duration of Alzheimer's disease, and it has been found to increase the activity of MMP9, thereby indirectly promoting aggregation and cerebral accumulation of tau deposits [47]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.